Takeda Pharmaceutical Co., Ltd. (TAK)
Takeda Pharmaceutical Market Cap : 68.47B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 68.47B |
| November 12, 2026 | 67.48B |
| November 11, 2026 | 66.58B |
| November 10, 2026 | 66.87B |
| November 09, 2026 | 67.38B |
| November 06, 2026 | 67.16B |
| November 05, 2026 | 67.70B |
| November 04, 2026 | 67.28B |
| November 03, 2026 | 66.29B |
| November 02, 2026 | 66.68B |
| October 30, 2026 | 66.81B |
| October 29, 2026 | 63.93B |
| October 28, 2026 | 64.38B |
| October 27, 2026 | 64.76B |
| October 26, 2026 | 65.27B |
| October 23, 2026 | 63.97B |
| October 22, 2026 | 64.35B |
| October 21, 2026 | 62.99B |
| October 20, 2026 | 63.46B |
| October 19, 2026 | 61.98B |
| October 16, 2026 | 62.17B |
| October 15, 2026 | 61.47B |
| October 14, 2026 | 60.08B |
| October 13, 2026 | 58.53B |
| October 12, 2026 | 59.04B |
| Date | Value |
|---|---|
| October 09, 2026 | 59.20B |
| October 08, 2026 | 58.53B |
| October 07, 2026 | 58.06B |
| October 06, 2026 | 57.21B |
| October 05, 2026 | 56.29B |
| October 02, 2026 | 56.45B |
| October 01, 2026 | 56.45B |
| September 30, 2026 | 57.49B |
| September 29, 2026 | 58.50B |
| September 28, 2026 | 59.74B |
| September 25, 2026 | 59.61B |
| September 24, 2026 | 58.76B |
| September 23, 2026 | 59.45B |
| September 22, 2026 | 59.89B |
| September 21, 2026 | 59.70B |
| September 18, 2026 | 59.77B |
| September 17, 2026 | 60.21B |
| September 16, 2026 | 58.91B |
| September 15, 2026 | 59.10B |
| September 14, 2026 | 58.79B |
| September 11, 2026 | 57.71B |
| September 10, 2026 | 57.24B |
| September 09, 2026 | 57.55B |
| September 08, 2026 | 57.90B |
| September 04, 2026 | 58.31B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Sanofi | 117.45B |
| Dr. Reddy's Laboratories Ltd. | 12.28B |
| Astellas Pharma, Inc. | 30.21B |
| Daiichi Sankyo Co., Ltd. | 32.74B |
| Eisai Co., Ltd. | 9.157B |
Market Cap Related Metrics
| PE Ratio | 348.46 |
| PS Ratio | 2.301 |
| Price to Book Value | 1.451 |
| Price to Free Cash Flow | 35.44 |
| Price | 21.43 |
| Earnings Yield | 0.29% |
| Operating PE Ratio | 12.85 |
| Normalized PE Ratio | 97.63 |